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Exposure to stress increases vulnerability to drug abuse, as well as relapse liability
in addicted individuals. Chronic drug use alters stress response in a manner that
increases drug seeking behaviors and relapse. Drug exposure and withdrawal have
been shown to alter stress responses, and corticosteroid mediators of stress have been
shown to impact addiction-related brain function and drug-seeking behavior. Despite
the documented interplay between stress and substance abuse, the mechanisms by
which stress exposure and drug seeking interact remain largely unknown. Recent
studies indicate that microRNAs (miRNA) play a significant role in stress modulation
as well as addiction-related processes including neurogenesis, synapse development,
plasticity, drug acquisition, withdrawal and relapse. MiRNAs are short non-coding
RNAs that function as bidirectional epigenetic modulators of gene expression through
imperfect sequence targeted degradation and/or translational repression of mRNAs.
They serve as dynamic regulators of CNS physiology and pathophysiology, and facilitate
rapid and long-lasting changes to complex systems and behaviors. MiRNAs function
in glucocorticoid signaling and the mesolimbic dopamine reward system, as well as
mood disorders related to drug withdrawal. The literature suggests miRNAs play a
pivotal role in the interaction between exposures to stress, addiction-related processes,
and negative affective states resulting from extended drug withdrawal. This manuscript
reviews recent evidence for the role of miRNAs in the modulation of stress and cocaine
responses, and discusses potential mediation of the interaction of these systems by
miRNAs. Uncovering the mechanism behind the association of stress and drug taking
has the potential to impact the treatment of drug abuse and prevention of relapse.
Further comprehension of these complex interactions may provide promising new
targets for the treatment of drug addiction.
Keywords: microRNA, stress, cocaine, extended amygdala, corticotropin-releasing factor, brain-derived
neurotrophic factor
Abbreviations: Ago, argonaute; Arc, activity-regulated cytoskeleton-associated protein; BDNF, brain derived neurotrophic
factor; BNST, bed nucleus of the stria terminalis; CREB, cAMP response element-binding protein; CRF, corticotrophin
releasing factor; Drd2, D2 dopamine receptors; ERK, Extracellular signal-regulated kinase; MAP3K8, mitogen-activated
protein kinase kinase kinase 8; MeCP2, methyl CpG binding protein 2; POMC, proopiomelanocortin; RISC,
RNA-induced silencing complex; SIRT, NAD-dependent deacetylase sirtuin; TLR, Toll-like receptor; TNF, tumor
necrosis factor; TORC, target of rapamycin complex; VTA, ventral tegmental area.
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NEUROCIRCUITS AND PATHWAYS
COMMON TO STRESS AND COCAINE
ABUSE
Considerable evidence supports the overlap between the stress
and reward systems of the brain and that alterations in stress
systems may contribute to increased liability to abuse drugs
including cocaine (de Jong and de Kloet, 2004). Both repeated
stress and psychostimulant dependence are associated with
alterations in the mesocorticolimbic dopamine system, the
medial prefrontal cortex glutamatergic corticolimbic circuit, and
corticotropin-releasing factor (CRF) signaling in the ventral
tegmental area (VTA; Piazza and Le Moal, 1997; Everitt and
Wolf, 2002).
The transition from drug-taking behavior to addiction
is characterized by a shift from positive drug reinforcement
involving dopamine signaling to negative reinforcement
involving the stress systems of the brain where drug-taking now
removes the dysphoria, anxiety and negative emotional state
experienced during abstinence/withdrawal (Koob and Le Moal,
2001). The extended amygdala, comprised of the bed nucleus of
the stria terminalis (BNST), central nucleus of the amygdala and
the nucleus accumbens shell, serves as a common circuit between
drug reward and the negative emotional state experienced during
abstinence/withdrawal (Alheid et al., 1998; Koob and Le Moal,
2001). The extended amygdala receives afferent connections
form limbic brain structures including the basolateral amygdala
and hypothalamus, and sends efferent projections to the medial
ventral pallidum and the lateral hypothalamus (Heimer et al.,
1991). The extended amygdala also has interconnections with the
VTA and ventral striatum. The BNST contains a large number
of dopamine and norepinephrine terminals, CRF terminals
and cell bodies, neuropeptide Y terminals, and receives afferent
connections from the prefrontal cortex (Allen et al., 1984; Phelix
and Paull, 1990; Pacak et al., 1995; Kozicz, 2001; Koob, 2003).
The extended amygdala functions in both the positive
reinforcing effects of drugs of abuse and the negative reinforcing
effects of drug abstinence and withdrawal. Drugs of abuse
including cocaine increase extracellular levels of dopamine
in the nucleus accumbens shell (Pontieri et al., 1995).
Further, withdrawal from cocaine increases extracellular
concentrations of CRF in the extended amygdala (Koob et al.,
1994). Rats receiving repeated injections of corticosterone
acquire cocaine self-administration at lower cocaine doses
relative to rats receiving vehicle (Deroche et al., 1997), and
blockade of glucocorticoid and CRF receptors suppresses
cocaine self-administration in rats (Piazza and Le Moal,
1996; Goeders, 1997). Taken together, these findings suggest
considerable overlap between and cross-regulation of the
stress and reward systems of the brain. Interaction between
the stress and reward systems can contribute to responding
to drugs of abuse and abstinence/withdrawal following
exposure to drugs of abuse. Long-lasting changes in the
stress and reward systems of the brain are known to play a
crucial role in the transition from recreational drug taking
to compulsive drug abuse. Understanding of the role of
miRNAs in the maintenance of homeostasis within and
between these brain systems will significantly improve our
understanding of the etiology of compulsive drug use and




Several recent studies demonstrate that miRNAs play a direct
and crucial role in the modulation of cocaine intake in rodent
models (Table 1). MiRNAs exert their regulatory translational
repression and degradation of mRNA through the RNA-
induced silencing complex (RISC). A core component of
the RISC complex is the Argonaute (Ago) miRNA binding
proteins, particularly Ago2 which mediates miRNA-dependent
degradation and translational repression of target mRNAs
(Hammond et al., 2001; Liu et al., 2004; Song et al., 2004)
and functions in the generation of selective miRNAs from
their precursors (Diederichs and Haber, 2007; O’Carroll et al.,
2007). Mice deficient in Ago2 expression in dopamine D2
(Drd2) expressing neurons in the striatum self-administer
significantly fewer infusions of cocaine with a downward
shift in the cocaine dose-response curve relative to control
animals expressing normal levels of Ago2 (Schaefer et al., 2010).
Further, in contrast to wild-type control mice, Ago2-deficient
mice show no preference for cocaine paired environments
in conditioned place preference experiments (Schaefer et al.,
2010). Deficient expression of Ago2 in the striatum results
in decreased expression of ∼25% of the examined miRNA
species, providing strong evidence for the modulation of
cocaine self-administration and reward by miRNAs through
the action of Ago2 in the RISC complex. Thus, Ago2 plays
a critical role in cocaine reward and motivation to self-
administer cocaine. Further, these studies demonstrate that
miRNAs function to modulate complex behavioral responses
through region specific post-transcriptional regulation of gene
expression.
Exposure to cocaine significantly alters miRNA expression in
many regions of the brain (Figures 1, 2). MiR-134 and miR-135a
are upregulated in the hippocampus following exposure to
cocaine (Chen et al., 2013). MiR-181a (Chandrasekar and
Dreyer, 2009), miR-212 (Hollander et al., 2010), and miR-
375 (Jonkman and Kenny, 2013) are upregulated in the
striatum following cocaine exposure. MiR-9 and miR-124 are
upregulated, whereas miR-183 is downregulated in striatal
post-synaptic densities (Eipper-Mains et al., 2011). Further,
altered expression of these miRNAs has been demonstrated
to have profound effects on cocaine reward and intake
(Table 1). For instance over-expression of miR-181a in the
nucleus accumbens increases cocaine-induced conditioned place
preference, whereasmiR-181a knockdown has the opposite effect
(Chandrasekar and Dreyer, 2011). Over-expression of miR-
124 in the nucleus accumbens attenuates cocaine conditioned
place preference (Chandrasekar and Dreyer, 2011). MiR-135a
is upregulated 2.5-fold and miR-134 is upregulated greater
than 7-fold following extinction of cocaine conditioned place
preference (Chen et al., 2013). MiR-134 functions in memory
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TABLE 1 | Behavioral effects and molecular targets/regulators of microRNA(miRNAs) expression.
miR Expression effects Targets/regulators
miR-181a Overexpression increases cocaine CPP (Chandrasekar and Dreyer, 2011) BDNF, SIRT1, GluA2 (Rivetti di Val Cervo et al., 2012;
Saba et al., 2012)
miR-124/124a Overexpression attenuates cocaine CPP (Chandrasekar and Dreyer, 2011) Mineralocorticoid receptor, BDNF, CREB
(Chandrasekar and Dreyer, 2009; Sõber et al., 2010)
miR-134 Modulates cocaine plasticity (Gao et al., 2010) CREB, BDNF, SIRT1 (Gao et al., 2010)
miR-135a Overexpression attenuates social defeat stress (Issler et al., 2014) Mineralocorticoid receptor, serotonin transporter
and receptor 1a (Sõber et al., 2010; Issler et al., 2014)
miR-375 BDNF, MAP3K8, POMC, CRF
(Abdelmohsen et al., 2010; Zhang et al., 2013)
miR-212 Overexpression decreases cocaine self-administration Down-regulation
increases cocaine self-administration (Hollander et al., 2010)
BDNF, CREB:TORC, MeCP2 (Hollander et al., 2010)
miR-183 mTor (Kye et al., 2014)
miR-9 BDNF, CREB, SIRT1 (Wu and Xie, 2006; Delaloy et al., 2010;
Dajas-Bailador et al., 2012)
miR-26a/26b BDNF, CREB (Caputo et al., 2011)
miR-449a Overexpression decreases CRF-R1 expression Down-regulation
attenuates CRF-R1 downregulation (Nemoto et al., 2012)
POMC, CRF-R1 (Nemoto et al., 2012)
miR-132 BDNF, CREB, glucocorticoids, ERK, SIRT1, glutamate
receptor (Strum et al., 2009; Kawashima et al., 2010;
Numakawa et al., 2011; Yi et al., 2014)
Let7 Modulates cocaine plasticity (Chandrasekar and Dreyer, 2009) SIRT1 (Helwak et al., 2013)
miR-34c Overexpression decreases anxiety-like behavior (Haramati et al., 2011)
miR-19b Androgenic receptor B1, PTEN (Olive et al., 2009; Volk et al., 2014)
formation and synaptic plasticity through sirtuin 1 (SIRT1),
and regulates expression of cAMP response element binding
protein (CREB) and brain-derived neurotrophic factor (BDNF)
(Gao et al., 2010). Chronic cocaine induces SIRT1 expression in
the nucleus accumbens (Ferguson et al., 2013). Over-expression
of SIRT1 in the accumbens increases the rewarding effects of
cocaine, and knockdown of SIRT1 has the inverse effect on
cocaine reward (Ferguson et al., 2013). Further, a recent study
by Quinn et al. (2015) identified several miRNAs predicted
to function in synaptic plasticity which show differential
expression in the dorsolateral and dorsomedial striatum of rats
with high versus low propensity to self-administer cocaine.
MiRs 101b, and 431 are significantly overexpressed, whereas
miR-212 is significantly underexpressed in the dorsomedial
striatum of the high cocaine responders. In the dorsolateral
striatum, miRs 101b, 132, 181a, 431, and 708 are significantly
overexpressed in vulnerable animals relative to those that
show resilience to cocaine seeking (Quinn et al., 2015). These
miRNAs may modulate responding to drugs of abuse through
regulation of LTD, LTP, and specifically activity-regulated
cytoskeleton-associated protein (Arc), a master regulator of
synaptic plasticity.
Evidence shows that miR-212 plays a particularly important
role in the modulation of cocaine intake. MiR-212 is upregulated
1.75-fold in the dorsal striatum of rats provided extended
daily access to cocaine self-administration compared to
restricted access and yoked rats (Hollander et al., 2010). Rats
overexpressing miR-212 in the dorsal striatum have lower
cocaine self-administration rates and a downward shift in
cocaine self-administration dose response under extended
access conditions relative to control animals, indicating a
decreased motivation to self-administer cocaine. Inhibition
of miR-212 increases cocaine intake and increases non-
reinforced responding suggesting that miR-212 modulates
cocaine intake and compulsive-like responding (Hollander
et al., 2010). These actions are mediated by the regulation
of CREB:TORC signaling by miR-212 in response to
cocaine exposure (Hollander et al., 2010). The regulation
of CREB signaling by cocaine is an established mechanism
contributing to the modulation of the rewarding effects
of cocaine (Carlezon et al., 1998; McClung and Nestler,
2003).
The kappa opioid system also plays a significant role
in the modulation of cocaine reward. Dynorphin, an
endogenous kappa opioid peptide, as well as exogenous
kappa opioid agonists decrease dopaminergic tone in the
striatum resulting in dysphoria and negative affective state
(Tejeda et al., 2012). Chronic exposure to cocaine upregulates
kappa opioid receptors and decrease dopaminergic activity
(Unterwald et al., 1994; Maisonneuve et al., 1995). Further,
stress induced activation of kappa opioid receptors through
release of dynorphin potentiates the rewarding effects
of cocaine as measured by conditioned place preference
(McLaughlin et al., 2003). Thus far, there is little data in
the literature on the regulation of kappa opioid receptors
or prodynorphin by miRNAs. However, it is known
that CREB regulates prodynorphin expression in rodents.
Overexpression of CREB increases the expression of dynorphin
whereas expression of mutant CREB has the opposite effect
(Carlezon et al., 1998). Several of the miRNAs discussed
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FIGURE 1 | Regulation of cocaine reward and stress by microRNAs (miRNAs). Chronic cocaine exposure has been shown to alter expression of a number
of miRNAs in various regions of the brain resulting in altered expression of down-stream molecular targets (Chandrasekar and Dreyer, 2009)1, (Chen et al., 2013)3,
(Eipper-Mains et al., 2011)4, (Hollander et al., 2010)6, (Jonkman and Kenny, 2013)7. This in turn effects responding in the stress and reward systems of the brain.
Exposure to stress regulates expression of miRNAs, and exogenous alteration of expression of several miRNAs regulated by cocaine and stress exposure alters the
rewarding effects of cocaine. Alteration of miRNA expression in the stress and reward systems together modulate cocaine intake in a feed-back regulatory loop
(Chandrasekar and Dreyer, 2011)2, (Haramati et al., 2011)5, (Hollander et al., 2010)6, (Mannironi et al., 2013)8, (Meerson et al., 2010)9, (Nemoto et al., 2012)10,
(Rinaldi et al., 2010)11, (Shimizu et al., 2015)12, (Volk et al., 2014)13, (Yi et al., 2014)14, (Zhang et al., 2015)15.
herein regulate CREB, and likely function to regulate kappa
opioid receptors and dynorphin through modulation of CREB
activity.
In addition to CREB signaling, miRNAs also regulate
BDNF which is known to function in the rewarding and
reinforcing actions of cocaine. The effects of BDNF on
cocaine reward and seeking behavior are brain region specific.
BDNF infusion into the nucleus accumbens and VTA enhance
the rewarding effects of cocaine (Lu et al., 2004; Graham
et al., 2007). In contrast, BDNF infusion into the prefrontal
cortex following cocaine self-administration attenuates cocaine
reinstatement via modulation of ERK, CREB and glutamate
signaling (Berglind et al., 2007, 2009; Whitfield et al., 2011).
MiR-212 indirectly regulates BDNF levels in the striatum of
mice undergoing extended access cocaine self-administration
through interaction with MeCP2 (Im et al., 2010). MeCP2
expression is positively correlated with BDNF expression,
and miR-212 expression is negatively correlated to BDNF
expression (Im et al., 2010). Increased expression of CREB
in the nucleus accumbens shell significantly increases cocaine
self-administration and motivation to self-administer cocaine
(Larson et al., 2011) and this may be related to BDNF
regulation. Animals overexpressing CREB have increased
expression of BDNF and a short-term upward and long-term
leftward shift in the cocaine dose-response curve for IV
self-administration. Further, increased CREB expression after
withdrawal reinforced cocaine-stimulated reinstatement (Larson
et al., 2011). Expression of BDNF is increased in midbrain and
amygdala during withdrawal from cocaine self-administration,
and is hypothesized to contribute to heightened motivation
to self-administer cocaine (Grimm et al., 2003; Lu et al.,
2004).
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FIGURE 2 | Brain region specific regulation of micrRNA expression by stress and cocaine. Regulation of microRNA expression by stress (red) and cocaine
(blue) occurs in a region specific manner. Stress and cocaine exposure alters microRNA expression in brain regions involved in stress (amygdala), reward (striatum),
and learning and memory (hippocampus and frontal cortex).
Increased BDNF activity in brain regions involved in drug
reward potentiates the reinforcing effects of cocaine. BDNF
infusions into the nucleus accumbens increases sensitivity to
the psychomotor stimulant effects of cocaine (Horger et al.,
1999) and increases cocaine self-administration behavior
in rodents (Graham et al., 2007). Further, knockdown of
BDNF in the accumbens decreases cocaine self-administration
(Graham et al., 2009). Knockdown of MeCP2 results in
increased expression of miR-212, whereas increased miR-212
expression decreased the expression of MeCP2 (Im et al.,
2010). Striatal MeCP2 knockdown decreases cocaine self-
administration and shifts the cocaine self-administration
dose-response curve down in animals given extended access.
Knockdown of miR-212 expression in the striatum of
MeCP2 deficient mice restores cocaine self-administration
and shifts the cocaine dose response curve back up to
control levels (Im et al., 2010). This suggests miR-212
represses expression of MeCP2 and is itself repressed by
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MeCP2 thereby regulating cocaine effects on striatal BDNF
expression. This negative homeostatic balance in turn regulates
the rewarding properties of cocaine and may contribute to
the escalation to compulsive drug seeking. Taken together,
these data provide strong evidence that miRNAs serve as
critical short-term and long-term epigenetic modulators of
cocaine exposure and reward through regulation of canonical
drug reward signaling cascades. Cocaine exposure alters
miRNA expression in several brain regions, and modulation
of regional expression of these miRNA species alters




In addition to the reward system, it is known that the
stress systems of the brain play a vital role in drug seeking
behavior. It is hypothesized that dysregulation of both the
reward and stress pathways of the brain lead to the transition
from recreational to compulsive drug seeking, and long-
term dysregulation of these systems leads to vulnerability to
relapse. Dopaminergic projections from the VTA to the medial
prefrontal cortex have been implicated in the stress-induced
relapse of cocaine-seeking in rodent reinstatement models
(Vranjkovic et al., 2014). Dopamine D1 receptor activation
in the VTA increases the activity of glutamatergic pathways
leading to the nucleus accumbens, thereby increasing cocaine
seeking (McFarland et al., 2004). Foot-shock stress increases
CRF release in the VTA which in turn increases glutamate
release activating mesocorticolimbic dopamine neurons and
inducing cocaine reinstatement in rats previously exposed
to cocaine self-administration (Wang et al., 2005). The
VTA functions in the modulation of reward as part of
the dopamine reward pathway and also receives inputs
from brain regions involved in the modulation of stress
response, including the extended amygdala (Phillipson, 1979).
Of particular interest is the BNST which functions in
the integration of stress and the reward system. Inhibition
of the central nucleus of the amygdala, ventral BNST,
and nucleus accumbens shell via co-infusion of baclofen
and muscimol prevents reinstatement of cocaine seeking
by foot shock stress (McFarland et al., 2004). Further,
the BNST is critical in swim-stress induced reinstatement
of cocaine seeking through CREB signaling (Briand et al.,
2010). These data provide strong evidence that the extended
amygdala is a critical region for the integration of stress
and reward signaling in the brain and plays an important
role in stress-induced drug-seeking behaviors. Recent evidence
shows that miRNA expression is significantly altered in
regions of the extended amygdala in response to acute and
chronic stress. Many of these miRNAs are also modulated
by cocaine exposure in reward regions thus suggesting that
miRNAs regulate both reward and stress signaling in the
brain. These complex interconnected regulatory cascades likely
contribute to the long-term dysregulation of the reward
and stress systems hypothesized to drive compulsive drug
seeking.
MICRORNAS MODULATE STRESS
RESPONSE AND NEGATIVE AFFECTIVE
STATES
MiRNAs play a role in the short-term and long-termmodulation
of stress response and contribute to the etiology of anxiety and
depression-like behaviors. Several miRNAs have been identified
that function in the modulation of stress responses including
miRNAs also shown to function in cocaine reward acting
through similar signaling pathways to affect stress response as
well as drug reward (Table 1). Mir-134 and miR-183 expression
is increased in the central nucleus of the amygdala in response to
acute immobilization stress, and miR-183 modulates expression
of SC35, a protein which regulates stress-induced alternative
splicing of acetylcholinesterase in vitro (Meerson et al., 2010).
Mannironi et al. (2013) demonstrated that miR-135a and
miR-124 are significantly down-regulated in mouse amygdala
following 2 h restraint and directly regulate expression of the
mineralocorticoid receptor, a regulator of early stress response.
In addition, miR-124 is upregulated by cholinergic agonists, and
plays a critical role in the cholinergic anti-inflammatory pathway
(Sun et al., 2013). Further, miR-375, which is upregulated
by repeated cocaine exposure, inhibits proopiomelanocortin
(POMC) expression by targeting MAP3K8 and mediating CRF
signaling (Zhang et al., 2013). Acute stress has also been shown
to alter expression of let-7a, miR-9 and miR-26a/b in the frontal
cortex (Rinaldi et al., 2010), and miR-124a (Shimizu et al., 2015)
in mouse corpus callosum. Expression of these same miRNAs is
also altered in the striatum by cocaine exposure (Eipper-Mains
et al., 2011).
The literature shows that these miRNAs, which aremodulated
by both drug and stress exposure, in turn modulate drug
seeking and stress response through transcriptional regulation of
downstream targets in interacting canonical pathways (Table 1).
For instance, chronic unpredictable stress decreases expression of
miR-9 in the nucleus accumbens leading to increased expression
of the dopamine D2 receptor (Zhang et al., 2015). Restraint
stress significantly increases expression of miR-449a, increases
expression of POMC mRNA, and decreases expression of
CRF-R1 mRNA and protein in the anterior pituitary of rats
(Nemoto et al., 2012). Further, over-expression of miR-449a
results in suppression of CRF-R1 mRNA and protein, and down-
regulation of miR-449a attenuates suppression of CRF-R1 by
dexamethasone in cultured anterior pituitary cells (Nemoto et al.,
2012). This suggests that miR-449a contributes to the stress-
induced down-regulation of CRF-R1 by glucocorticoids in the
anterior pituitary. MiR-132 is upregulated by BDNF (Numakawa
et al., 2011) and down-regulated by glucocorticoids (Kawashima
et al., 2010) in cultured cells. Yi et al. (2014) have shown thatmiR-
132 is down-regulated in the hippocampus of mice exposed to
chronic unpredictablemild stress. Further, evidence suggests that
miR-132 expression is regulated by the ERK signaling pathway
(Remenyi et al., 2010). MiR-132 alsomodulates Toll-like receptor
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(TLR) signaling pathways via regulation of acetylcholinesterase
to increase acetylcholine-mediated negative regulation of TLR-
signaling pathways (Shaked et al., 2009).
MiR-34c is upregulated in the amygdala of mice exposed
to acute restraint stress and repeated social defeat stress,
and over-expression of miR-34c in the amygdala protects
against the anxiogenic effects of acute restraint stress possibly
through regulation of CRF-R1 (Haramati et al., 2011). MiR-19b
selectively associates with Ago2, is significantly upregulated in
the amygdala of mice exposed to chronic social defeat stress,
and regulates expression of adrenergic receptor β1 in vitro (Volk
et al., 2014). MiR-124a is upregulated in the hippocampus of
adult rats exposed to social defeat stress (Bahi et al., 2014).
MiR-124a is a direct regulator of BDNF expression, and as
expected, BDNF is down-regulated in hippocampus of rats
after social defeat stress, and over-expression of miR-124a
in rat hippocampus exacerbates social defeat stress-induced
depression-like behaviors as measured by novelty suppressed
feeding, sucrose preference and force swim tests (Bahi et al.,
2014). Recently, it was demonstrated that both activation of
VTA- accumbens neurons and subthreshold social defeat
stress stimulation are required to induce upregulation of
BDNF in a CRF receptor dependent manner in the nucleus
accumbens (Walsh et al., 2014). Further, accumbens BDNF
promotes increases in cocaine self-administration and relapse
(Graham et al., 2007). Dwivedi et al. (2015) have shown that
chronic administration of corticosterone differentially regulates
expression of 26 miRNAs in the prefrontal cortex, several
of which (miRs 19b, 124, 181a, 135a) regulate responding
to cocaine exposure. The majority of these miRNAs show
binding sites for glucocorticoid receptor elements, suggesting
a common regulatory pathway for miRNA regulation of
corticosterone able to cross-talk with reward and synaptic
plasticity pathways. MiR-181 suppresses TNF-induced
cytokine production through regulation of p300/cyclic
AMP response element binding protein-associated factor,
demonstrating an integral role of miRNAs in inflammatory
and immune responses (Zhao et al., 2012). These data suggest
miRNAs shown to modulate cocaine-seeking behaviors, also
contribute to the regulation of stress response, anxiety-like
behaviors and anhedonia. Further this strongly suggests
a role for miRNAs in the modulation of the observed
interactions between stress exposure/response and drug
reward.
SUMMARY
MicroRNAs (miRNAs) play significant roles in the modulation
of both the stress and reward systems of the brain. The literature
has long documented that both the reward and stress systems
function in responding to the acute effects of drugs of abuse,
as well as withdrawal/abstinence from chronic drug exposure.
Chronic exposure to cocaine results in dysregulation of brain
reward circuitry and recruitment of the brain stress systems
leading to long-term cocaine dependence. Long lasting changes
in both reward and stress systems lead to increased vulnerability
to relapse during periods of abstinence. Several miRNAs have
been identified which are co-regulated by chronic cocaine
exposure and various models of rodent stress responding.
These include, but are not limited to miR-134, 135a, 375,
and the miR-212/132 family. Further, these miRNAs function
in signaling pathways long known to regulate reward and
stress response such as dopamine and CRF signaling, and
glutamate transmission. It is well-established that CREB, CRF,
and BDNF, among other molecules, play key roles in both
stress and drug seeking/abuse. These molecules are therefore
widely theorized to mediate the interaction between stress
and drug seeking/abuse. Further, many of the miRNAs shown
to regulate these molecules also function in immune and
inflammatory responses, mechanisms known to play vital roles
in the etiology of addiction. For instance, miR-132 and miR-
212, shown to play a critical role in cocaine self-administration,
also play important roles in TLR2 ligand-mediated TNF-α
secretion (Nahid et al., 2013). The kappa opioid system is also
known to modulate both stress response and the rewarding
properties of drugs of abuse. However, to date, few studies have
examined the regulation of kappa opioid signaling by miRNAs.
These interactions are currently not very well understood,
however, deciphering these complex signaling pathways will
be vital to furthering our understanding of the addicted
brain.
This review posits that miRNAs serve as master regulators
of both the stress and reward systems through coordinated
regulation of a large number key molecules and facilitate
cross-talk between stress, reward, synaptic plasticity, and
immune/inflammatory responses. Through integration of these
signaling pathways, miRNAs serve as master regulators of
downstream behavioral and cellular responses to drugs of
abuse. In turn, miRNA expression is itself regulated by external
stimuli including stress and drug exposure. MicroRNAs are
highly conserved between species, however, species specific
differences do exist. Within species, there are tissue and cell
type differences in expression regulated by post-transcriptional
modification of more ubiquitously expressed pre-miRNAs. This
is likely necessary due to the ability of a single miRNA to
regulate numerous target genes. While the complexity of miRNA
regulation of gene expression poses a daunting challenge, it
is an area of study that holds immense promise for future
advancement of drug abuse research and the biomedical sciences
as a whole. We argue that miRNAs co-regulated by stress
and chronic cocaine represent prime targets for study in order
to further elucidate the etiology of the transition from casual
drug use to drug dependence. Further, this population of
miRNAs represents promising targets for identification of novel
treatments for drug abuse.
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